4//SEC Filing
Zeidan Ryan 4
Accession 0001209191-20-006355
CIK 0001544227other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:30 PM ET
Size
5.6 KB
Accession
0001209191-20-006355
Insider Transaction Report
Form 4
Zeidan Ryan
Chief Development Officer
Transactions
- Award
Employee Stock Option (right to buy)
2020-01-31+41,250→ 41,250 totalExercise: $7.94Exp: 2030-01-30→ Common Stock (41,250 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on January 7, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Millendo Therapeutics, Inc.
CIK 0001544227
Entity typeother
Related Parties
1- filerCIK 0001785724
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:30 PM ET
- Size
- 5.6 KB